ArticleJournal of neuromuscular diseases2025
Some functional improvements in placebo and Delandistrogene moxeparvovec-treated trial participants explained by increased corticosteroid dosing.
Eric P Hoffman et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.